ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 454,500
+5,000 (1.11%)
Jan 2, 2026, 1:10 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 24.04 trillion as of December 31, 2025. Its market cap has increased by 49.36% in one year.
Market Cap
24.04T
Enterprise Value
23.79T
Revenue
202.18B
Ranking
n/a
PE Ratio
198.63
Stock Price
454,500.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 24.04T, an increase of 19,940.90%. That is a compound annual growth rate of 61.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.46T |
| Celltrion | 39.60T |
| ABL Bio | 11.03T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.39T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.32T |
| Peptron | 5.92T |